68Ga-FAPI

gallium-68 labeled fibroblast activation protein inhibitor

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for 68Ga-FAPI, covering 2024-09-19 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: 68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer

See pricing